[1] 中华医学会肝病学分会脂肪肝和酒精性肝病学组.非酒精性脂肪性肝病诊疗指南［J］.中华肝脏病杂,2010,18(3): 164.
[2] Bedogni G,Miglioli L,Masutti F,et al.lncidence and natural course of fatty liver in the general population:the Dionysos study ［J］.Hepatology,2007,46(5):1387－1391.
[3] Hui JM,Hodge A,Farrell GC,et al.Beyond insulin resistance in NASH:TNF-or adiponectin? ［J］.Hepatology,2004,40(1) :46-54.
[4] Fabbrini E,Sullivan S,Klein S.Obesity and nonalcoholic fatty liver disease: biochemical,metabolic,and clinical implications ［J］.Hepatology,2010,51(2):679－689.
[5] Andrieu-Abadie N,Jafrezou JP,Hatem S,et al.L-Carnitine prevents doxorubicin-induced apoptosis of cardiac myocytes:role of inhibition of ceramide generation［J］.Fed Am Soc Exp Biol J,1999,13(12):1501－1510 .
[6] Kumaran S,Deepak B,Naveen B,et al.Efects of levocarnitine on mitochondrial antioxidant systems and oxidative stress in aged rats ［J］.Drugs RD,2003,4(3):141－147.
[7] Evans AM,Fornasini G. Pharmacokinetics of L-carnitine［J］.Clin Pharmacokinet,2003,42(11):941－967.
[8] Sirtori C,Calabresi L,Ferrara S,et al.L-carnitine reduces plasma lipoprotein( a) levels in patients with hyper Lp( a) ［J］.Nutr Metab Cardiovasc Dis,2000,10(5) :247－251.
[9] Mingrone G,Greco AV,Capristo E,et al.L-carnitine improves glucose disposal in type 2 diabetic patients［J］.J Am Coll Nutr,1999,18(1):77－82.
[10] Power RA,Hulver MW,Zhang JY,et al.Carnitine revisited:potential use as adjunctive treatment in diabetes［J］.Diabetologia,2007,50(4):824－832.
[11] Malaguarnera M,Gargante MP,Russo C,et al.L-carnitine supplementation to diet:a new tool in treatment of nonalcoholic steatohepatitis-a randomized and controlled clinical trial［J］.Am J Gastroenterol,2010,105(6):1338－ 345.